An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis With Uncertain Etiology in the Context of Chronic Myeloid Leukemia

Yuanzun Peng^{1

2}, Anusha S Thomas¹, Dongguang Wei³, Dongfeng Tan³, Yinghong Wang¹

Affiliations

¹ Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Biosciences, Rice University, Houston, Texas, USA.
³ Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Case Reports

Yuanzun Peng et al. Inflamm Bowel Dis. 2020.

. 2020 Mar 4;26(4):e26-e27.

doi: 10.1093/ibd/izaa016.

Yuanzun Peng^{1

2}, Anusha S Thomas¹, Dongguang Wei³, Dongfeng Tan³, Yinghong Wang¹

¹ Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Biosciences, Rice University, Houston, Texas, USA.
³ Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

No abstract available

Keywords: ulcerative colitis; cancer; fecal microbiota transplantation; imatinib.

Publication types